When to Stop Aspirin and Clopidogrel Before Surgery
For aspirin (ASA), stop ≤7 days before surgery in patients at low cardiovascular risk, but continue perioperatively in patients at moderate-to-high cardiovascular risk; for clopidogrel (Plavix), stop 5 days before surgery. 1, 2
Aspirin (ASA) Management
The timing of aspirin discontinuation depends critically on the patient's cardiovascular risk profile:
High/Moderate Cardiovascular Risk Patients
- Continue aspirin throughout the perioperative period for patients receiving ASA for secondary prevention of cardiovascular disease 1
- This includes patients with:
- Continue aspirin for CABG surgery 1
Low Cardiovascular Risk Patients
- Stop aspirin ≤7 days (not the traditional 7-10 days) before surgery 1, 3
- The updated 2022 American College of Chest Physicians guidelines shortened this window from the previous 7-10 day recommendation 1
Minor Procedures
- Continue aspirin for minor dental procedures, dermatologic procedures, and cataract surgery regardless of cardiovascular risk 1
Critical Exception - High Bleeding Risk Surgeries
- Stop aspirin 5-7 days preoperatively for neurosurgery and other closed-space surgeries where even minor bleeding can cause severe complications (intracranial surgery, spinal canal surgery, posterior chamber eye surgery) 3, 4
Clopidogrel (Plavix) Management
Stop clopidogrel 5 days before surgery in most circumstances 1, 2, 5
Key Considerations:
- Clopidogrel irreversibly inhibits platelet function for the lifetime of the platelet (7-10 days) 5
- The 5-day window allows sufficient time for new platelet generation 2
- For CABG surgery specifically, stopping clopidogrel 5 days preoperatively reduces major bleeding risk by approximately 50% and transfusion requirements by 70% 1
Patients with Coronary Stents - Critical Exception
This is the most important clinical scenario requiring deviation from standard recommendations:
- Defer elective surgery for at least 6 weeks after bare-metal stent placement and 6 months after drug-eluting stent placement 1
- If surgery cannot be deferred and must occur within these timeframes, continue dual antiplatelet therapy (both aspirin and clopidogrel) perioperatively despite bleeding risk 1
- The thrombotic risk of stent thrombosis substantially outweighs surgical bleeding risk in this population 6
- After 6 months post-drug-eluting stent: continue aspirin but stop clopidogrel 5 days before surgery 1
Resumption of Therapy
Resume both aspirin and clopidogrel within 24 hours after surgery when adequate hemostasis is achieved 1, 2, 3
- The FDA label for clopidogrel specifically states to "restart it as soon as possible" after temporary discontinuation 5
- Some experts recommend a 300 mg loading dose of clopidogrel when resuming therapy in patients with drug-eluting stents 2
- Earlier resumption (within 12 hours) may be appropriate for very high thrombotic risk patients 7
Common Pitfalls to Avoid
Discontinuing Too Early
- Many clinicians still use the outdated 7-10 day window for aspirin when ≤7 days is now recommended 1, 3
- This unnecessarily prolongs the period of increased thrombotic risk 3
Inadequate Medication Reconciliation
- Patients frequently fail to report over-the-counter NSAIDs with antiplatelet effects 2, 3
- Always perform thorough medication reconciliation including all OTC medications 3
Bridging with Heparin
- Do not attempt to "bridge" antiplatelet therapy with heparin or low-molecular-weight heparin 6
- Heparin does not provide protection against coronary artery or stent thrombosis in patients who require antiplatelet therapy 6
Multiple Antiplatelet/Anticoagulant Agents
- Bleeding risk increases significantly when multiple antiplatelet or anticoagulant medications are combined 2, 3
- Carefully assess the cumulative bleeding risk in these patients 3
Emergency Reversal
- If urgent surgery is needed in a patient on clopidogrel, platelet transfusions may restore hemostasis, but are less effective within 4 hours of the loading dose or 2 hours of the maintenance dose 5
- For aspirin, the effect is irreversible and only fresh platelets can restore normal hemostasis (at least 20% of circulating platelets must have normal function) 6